Healthcare -
Biotechnology - NASDAQ - US
$ 7.2
-2.3 %
$ 6 M
Market Cap
-0.01
P/E
RNAZ - NET INCOME
Net Income RNAZ - TransCode Therapeutics, Inc.
-16.8 M
LAST VALUE
2.33%
2 YEAR CAGR
-94.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR